Eudaimonia Partners, LLC Vertex Pharmaceuticals Inc Transaction History

Eudaimonia Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 24, 2023	BUY	$285.76 - $321.48 $534,656 - $601,489	1,871 Added 75.9%	4,336 $0
Q3 2022 Nov 03, 2022	BUY	$273.83 - $305.53 $674,990 - $753,131	2,465 New	2,465 $714,000
Q2 2021 Aug 13, 2021	SELL	$187.49 - $221.1 $55,872 - $65,887	-298 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $2,484 - $2,895	-12 Reduced 3.87%	298 $64,000
Q4 2020 Feb 18, 2021	SELL	$207.01 - $276.09 $4,554 - $6,073	-22 Reduced 6.63%	310 $73,000
Q3 2020 Nov 16, 2020	BUY	$255.65 - $303.1 $15,594 - $18,489	61 Added 22.51%	332 $90,000
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $18,714 - $24,551	-83 Reduced 23.45%	271 $79,000
Q1 2020 May 05, 2020	BUY	$199.77 - $247.81 $7,990 - $9,912	40 Added 12.74%	354 $84,000
Q4 2019 May 05, 2020	BUY	$166.71 - $223.91 $52,346 - $70,307	314 New	314 $69,000

1,717

226M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $133B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Eudaimonia Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Eudaimonia Partners, LLC with notifications on news.